Cargando…

Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL

TRAIL [TNF (tumour necrosis factor)-related apoptosis-inducing ligand] is a promising agent for clinical use since it kills a wide range of tumour cells without affecting normal cells. We provide evidence that pretreatment with etoposide significantly enhanced TRAIL-mediated apoptosis via up-regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hye Ryung, Lee, Myoung Woo, Kim, Dae Seong, Jo, Ha Yeong, Lee, Soo Hyun, Chueh, Hee Won, Jung, Hye Lim, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475444/ https://www.ncbi.nlm.nih.gov/pubmed/23124518 http://dx.doi.org/10.1042/CBR20110008

Ejemplares similares

Inhibition of N‐myc expression sensitizes human neuroblastoma IMR‐32 cells expressing caspase‐8 to TRAIL
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
por: Lee, Myoung Woo, et al.
Publicado: (2015)

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
por: Bae, Soo Jin, et al.
Publicado: (2012)

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
por: Sung, Ki Woong, et al.
Publicado: (2002)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Neuroblastoma Originating from Extra-abdominal Sites: Association with Favorable Clinical and Biological Features
por: Sung, Ki Woong, et al.
Publicado: (2009)

Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2015)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density
por: Kim, Dae Seong, et al.
Publicado: (2014)

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
por: Lee, Na Hee, et al.
Publicado: (2016)

Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014)

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
por: Seo, Eunseop, et al.
Publicado: (2019)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
por: Lim, Hana, et al.
Publicado: (2020)

ARID1B alterations identify aggressive tumors in neuroblastoma
por: Lee, Soo Hyun, et al.
Publicado: (2017)

High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
por: Suh, Jung Min, et al.
Publicado: (2009)

Effect of Ex Vivo Culture Conditions on Immunosuppression by Human Mesenchymal Stem Cells
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
por: Kim, Jung Lim, et al.
Publicado: (2019)

Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ
por: Kim, Dae Seong, et al.
Publicado: (2018)

Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children
por: Bae, Joon Seol, et al.
Publicado: (2020)

Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
por: Vaculova, Alena, et al.
Publicado: (2010)

Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
por: Jo, Min Jee, et al.
Publicado: (2020)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
por: Seo, Eun Seop, et al.
Publicado: (2020)

Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors
por: Ji, Suntae, et al.
Publicado: (2011)

Sea Cucumber (Stichopus japonicas) F2 Enhanced TRAIL-Induced Apoptosis via XIAP Ubiquitination and ER Stress in Colorectal Cancer Cells
por: Kim, Jung Lim, et al.
Publicado: (2019)

Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
por: Kim, Ki-Uk, et al.
Publicado: (2005)

Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy
por: Kim, Jinsup, et al.
Publicado: (2015)

Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center.
por: Yoo, Keon Hee, et al.
Publicado: (2002)

Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells
por: Park, Seong Hye, et al.
Publicado: (2016)

Improved Outcome of Central Nervous System Germ Cell Tumors: Implications for the Role of Risk-adapted Intensive Chemotherapy
por: Yoo, Keon Hee, et al.
Publicado: (2010)

Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
por: Cho, Hee Won, et al.
Publicado: (2018)

Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Lee, Sae-Mi, et al.
Publicado: (2017)

Pancreatic Metastasis in a Child Suffering with Treated Stage 4 Neuroblastoma
por: Kim, Eun Young, et al.
Publicado: (2008)

Distinct effects of etoposide on glutamine-addicted neuroblastoma
por: Valter, Kadri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d8negbhm1es9k0la3n9lu7rgi1